L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis
NCT00851838
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
5
Enrollment
INDUSTRY
Sponsor class
Conditions
End-Stage Renal Disease
Interventions
DRUG:
L-Carnitine
Sponsor
Iperboreal Pharma Srl